2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma
Status:
RECRUITING
Trial end date:
2033-07-17
Target enrollment:
Participant gender:
Summary
The main objective of this trial was to determine the value of 2 courses of cisplatin concurrent chemotherapy in postoperative adjuvant radiotherapy for high-risk head and neck squamous cell carcinoma.
Phase:
PHASE3
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Guilin Medical University, China Hunan Cancer Hospital Jiangsu Cancer Institute & Hospital Xiangya Hospital of Central South University